It’s all done via Steve Albini’s Closet where you can by books, LPs, CDs, posters, t-shirts, flyers, zines, posters/flyers, “mysterious bargains,” and more from his collection.

LPs are making fund managers shrink; Many prefer it that way Traditionally, larger funds meant higher assets under management (AUM) and, in turn, greater compensation for managers.

The firm’s new LPs include giant pension plans, insurers, banks, and an Asian sovereign, Farmer said. Indeed, CalPERS, the largest pension fund in the U.S., has reportedly committed $100 million ...

LPs committed to diversity ‘will remain committed’ in the face of the fierce governmental anti-DEI push, an issue of acute interest for women in private equity. Sign in or Register.

MRT-6160, VAV1-directed MGD for immune-mediated conditions. Today, Monte Rosa announced clinical results from its MRT-6160 Phase 1, ... and substantial reductions of inflammatory cytokines in an ...

LPs want more consistency in the way GPs share information. LPs cite seven issues that they wish fund managers better understood about their needs, in exclusive research for PEI’s NEXUS event.

“What I’m all about,” he said, “is saving the world from bad sound.” Introduced in 1948, vinyl LPs seemed destined for extinction by the early 2000s, if not before, as the music industry ...

LPS recently changed the rules for its after-school symphonies to accept only students who attend the district, leaving private and homeschooled students and their families looking for answers.

LPS will spend 4.11% more on salary and benefits for teachers next year, which includes a base raise and additional pay increases based on longevity and professional development.

More than 100 tower blocks across the capital have been built with prefabricated concrete panels known as a Large Panel System (LPS), many of which could have safety issues, a BBC London ...

MRT-6160, VAV1-directed MGD for immune-mediated conditions. Today, ... and substantial reductions of inflammatory cytokines in an LPS-induced murine model of neuroinflammation.

--Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company developing novel molecular glue degrader- based medicines, today announced the closing of the Company’ s previously ...